Evidence map›Paper›PMID 19374902›Full record

ArticleExperimental neurology2009

Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation.

David L Schonberg, Dana M McTigue

Abstract read
In one paragraph

Article in Experimental neurology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Divalent Metal Transporter 1 (DMT1) Is Required for Iron Uptake and Normal Development of Oligodendrocyte Progenitor Cells.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David L SchonbergThe Neuroscience Graduate Studies Program, The Ohio State University, Columbus, OH, USA.
Dana M McTigue
The Ohio State University · US

Funding

Ohio State Neuroscience Centr CoreP30NS045758 · NINDS · OHIO STATE UNIVERSITY · PI OBRIETAN, KARL H · 2004 to 2015
$7.7M
Oligodendrocyte Genesis after Spinal Cord InjuryR01NS059776 · NINDS · OHIO STATE UNIVERSITY · PI MCTIGUE, DANA M · 2009 to 2013
$1.7M
Oligodendrocyte Progenitors in Spinal Cord Injury RepairR01NS043494 · NINDS · OHIO STATE UNIVERSITY · PI MCTIGUE, DANA M · 2003 to 2006
$1.1M
NINDS NIH HHS NS043494NINDS NIH HHS NS059776NINDS NIH HHS P30 NS045758NINDS NIH HHS P30-NS045758NINDS NIH HHS R01 NS043494NINDS NIH HHS R01 NS059776
6 · The paper itself

Abstract

Progenitor proliferation and differentiation are necessary for oligodendrocyte replacement. Previously, we showed that intraspinal activation of microglia and macrophages with the TLR4 agonist lipopolysaccharide (LPS) induced robust oligodendrocyte genesis. In this study we investigated whether this process involves iron since LPS can alter macrophage regulation of iron and its storage protein ferritin, and oligodendrocytes require iron for proper development and myelination. Further, activated macrophages can sequester and release iron and ferritin. We first examined whether iron or ferritin was present following LPS microinjection. Using Perl's stain, we noted a slight increase in iron at 1d, and peak iron levels 3d post-injection coincident with maximal macrophage activation. Ferritin+ cells were prevalent by 3d and included macrophages and NG2 cells (putative oligodendrocyte progenitors). At 7d, ferritin was mainly expressed by new oligodendrocytes prevalent throughout the lesions. Because of the timing and distribution of iron and ferritin after LPS, we next used an iron chelator to test whether free iron was necessary for maximal LPS-induced oligodendrocyte genesis. Chelating iron by Deferasirox (Exjade) after LPS microinjection significantly reduced the number of proliferating NG2 cells and new oligodendrocytes. Of the remaining oligodendrocytes, there was a 2-fold decrease in those expressing ferritin, revealing that the number of oligodendrocytes with high iron stores was reduced. Collectively, these results establish that iron accumulates after intraspinal TLR4 activation and is required for maximal TLR4-induced oligodendrogenesis. Since TLR4 agonists are abundant in CNS injury/disease sites, these results suggest that iron may be essential for macrophage/oligodendrocyte communication and adult glial replacement.

Indexed as

Cell ProliferationAnimalsAntigensBenzoatesBromodeoxyuridineCD11b AntigenChondroitin Sulfate Proteoglycan 4DeferasiroxDose-Response Relationship, DrugDrug Administration ScheduleFemaleFerritinsGene Expression RegulationInjections, SpinalIntracellular Signaling Peptides and ProteinsIronAntigensBenzoatesBromodeoxyuridineCD11b AntigenChondroitin Sulfate Proteoglycan 4DeferasiroxFerritinsIntracellular Signaling Peptides and ProteinsIronIron Chelating AgentsLipopolysaccharidesProteoglycansTriazoles

Identifiers

PMID19374902
PMCPMC2703190
OpenAlexW2158768678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.